Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jun 8;5(2):155–167. doi: 10.1007/s40120-016-0047-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2016

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 3 — BETACONNECT, Autoject and Rebiject, compared individually against an ideal autoinjector across 18 attributes. Attribute ratings for an ideal autoinjector are also shown (green bars). Autoject, Rebiject and BETACONNECT were rated based on how well they performed across the attributes, from 1 (not well) to 10 (very well). For each attribute, the percentage of patients who selected a rating of 8, 9, or 10 for each autoinjector using symbols as shown in the legend. Note: we did not compare Extavia patients separately vs. other groups because there were only two patients using Extavia. The other groups had enough patients for us to analyze and compare them. The two patients using Extavia autoinjectors were included in the total number of 90 patients (all patients following the demonstration and simulated injections with BETACONNECT)